Edgestream Partners L.P. Has $1.26 Million Holdings in Waters Co. (NYSE:WAT)

Edgestream Partners L.P. cut its stake in shares of Waters Co. (NYSE:WAT) by 22.8% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,716 shares of the medical instruments supplier’s stock after selling 1,395 shares during the period. Edgestream Partners L.P.’s holdings in Waters were worth $1,257,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Commonwealth Equity Services LLC increased its holdings in shares of Waters by 5.3% during the second quarter. Commonwealth Equity Services LLC now owns 9,608 shares of the medical instruments supplier’s stock worth $2,561,000 after buying an additional 481 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of Waters by 2.8% in the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 22,635 shares of the medical instruments supplier’s stock worth $6,033,000 after purchasing an additional 616 shares during the last quarter. US Bancorp DE grew its stake in shares of Waters by 9.6% in the second quarter. US Bancorp DE now owns 2,179 shares of the medical instruments supplier’s stock worth $581,000 after purchasing an additional 191 shares during the last quarter. Private Advisor Group LLC grew its stake in shares of Waters by 2.4% in the second quarter. Private Advisor Group LLC now owns 5,611 shares of the medical instruments supplier’s stock worth $1,518,000 after purchasing an additional 134 shares during the last quarter. Finally, Cetera Advisor Networks LLC grew its stake in shares of Waters by 7.2% in the second quarter. Cetera Advisor Networks LLC now owns 2,961 shares of the medical instruments supplier’s stock worth $789,000 after purchasing an additional 199 shares during the last quarter. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Waters Price Performance

Shares of NYSE WAT opened at $261.04 on Tuesday. The firm’s 50-day moving average price is $260.15 and its 200-day moving average price is $267.56. Waters Co. has a 1-year low of $231.90 and a 1-year high of $353.70. The firm has a market capitalization of $15.44 billion, a P/E ratio of 23.71, a P/E/G ratio of 5.83 and a beta of 0.90. The company has a current ratio of 2.19, a quick ratio of 1.46 and a debt-to-equity ratio of 2.71.

Waters (NYSE:WAT) last announced its quarterly earnings data on Tuesday, November 7th. The medical instruments supplier reported $2.84 earnings per share for the quarter, beating the consensus estimate of $2.56 by $0.28. Waters had a net margin of 21.80% and a return on equity of 102.22%. The firm had revenue of $711.69 million for the quarter, compared to analyst estimates of $722.27 million. During the same quarter in the prior year, the business earned $2.64 earnings per share. The business’s quarterly revenue was up .4% compared to the same quarter last year. Equities research analysts anticipate that Waters Co. will post 11.69 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

WAT has been the topic of several analyst reports. Wells Fargo & Company reduced their price objective on shares of Waters from $305.00 to $285.00 and set an “equal weight” rating on the stock in a research note on Wednesday, November 8th. Barclays cut shares of Waters from an “equal weight” rating to an “underweight” rating and reduced their price objective for the stock from $270.00 to $230.00 in a research note on Monday, November 13th. Stifel Nicolaus cut their price target on shares of Waters from $305.00 to $290.00 and set a “hold” rating on the stock in a research report on Wednesday, November 8th. Sanford C. Bernstein initiated coverage on shares of Waters in a research report on Thursday, September 28th. They set a “market perform” rating and a $280.00 price target on the stock. Finally, TheStreet cut shares of Waters from a “b-” rating to a “c+” rating in a research report on Wednesday, October 18th. One investment analyst has rated the stock with a sell rating and nine have issued a hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $298.00.

Waters Company Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.